Kevin E. Fisher, MD, PhD
- Pathology
Medical Director of Molecular Oncology
Associate Professor of Pathology & Immunology, Baylor College of Medicine
Phone:
832-824-2250
Languages: English
Departments:
Office location:
6621 Fannin Street
Houston, TX 77030
Get to know Kevin E. Fisher, MD, PhD
Dr. Fisher's research interests encompass molecular oncology and focus namely on the application of genomic technologies to the diagnosis and management of pediatric solid tumors and hematologic malignancies. His clinical interests focus on the development and implementation of combined targeted next-generation sequencing and cytogenetic assays to provide diagnostic and prognostic information for pediatric patients with acute leukemia.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Emory University Hospital | Fellowship | Molecular Genetic Pathology | 2014 |
| Emory University Hospital | Residency | Anatomic & Clinical Pathology | 2013 |
| University of Missouri-Columbia | Medical School | Doctor of Medicine | 2009 |
| University of Missouri-Columbia | PhD | Doctor of Philosophy | 2009 |
Organizations
| Organization Name | Role |
|---|---|
| Association for Molecular Pathology | Associate Member |
| United States and Canadian Academy of Pathology | Junior Member and House staff Representative for the National Education Committee |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH 3rd, Longshore JW. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Human Pathology 2014 Aug 7.
View All Publications:
http://www.ncbi.nlm.nih.gov/pubmed?term=Fisher%2C%20Kevin%20E%5BAuthor%…